Acute Candesartan Cilexetil Evaluation in Stroke Survivors "ACCESS"

Completed

Phase N/A Results

Summary of Purpose

To evaluate the effectiveness of an early, moderate BP reduction in patients with acute cerebral ischemia in comparison to restrictive antihypertensive therapy.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 18 July 2002.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • AstraZeneca GmbH Germany

Trial Design

Double-blind, randomized, multicenter trial with a planned enrollment of 500 patients. 342 patients randomized from 53 centers.

Contacts

  • Prof. Dr. J. Schrader St. Josefs Hospital Ritterstr 17, D-49661 Cloppenburg, Germany

    J.R.Schrader@t-online.de